Literature DB >> 22549249

Paediatric rheumatology: Corticosteroids as primary therapy in Kawasaki disease.

Rebecca Reindel, Stanford T Shulman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22549249     DOI： 10.1038/nrrheum.2012.65

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.

Authors:  Shohei Ogata; Yoshihito Ogihara; Takashi Honda; Shinya Kon; Kazumasa Akiyama; Masahiro Ishii
Journal:  Pediatrics       Date:  2011-12-05       Impact factor: 7.124

2.  Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.

Authors:  Tohru Kobayashi; Tsutomu Saji; Tetsuya Otani; Kazuo Takeuchi; Tetsuya Nakamura; Hirokazu Arakawa; Taichi Kato; Toshiro Hara; Kenji Hamaoka; Shunichi Ogawa; Masaru Miura; Yuichi Nomura; Shigeto Fuse; Fukiko Ichida; Mitsuru Seki; Ryuji Fukazawa; Chitose Ogawa; Kenji Furuno; Hirohide Tokunaga; Shinichi Takatsuki; Shinya Hara; Akihiro Morikawa
Journal:  Lancet       Date:  2012-03-08       Impact factor: 79.321

3.  Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.

Authors:  Ja-Young Hwang; Kyung-Yil Lee; Jung-Woo Rhim; You-Sook Youn; Jin-Hee Oh; Ji-Whan Han; Joon-Sung Lee; David Burgner
Journal:  Arch Dis Child       Date:  2010-06-15       Impact factor: 3.791

4.  Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.

Authors:  Lynn A Sleeper; L Luann Minich; Brian M McCrindle; Jennifer S Li; Wilbert Mason; Steven D Colan; Andrew M Atz; Beth F Printz; Annette Baker; Victoria L Vetter; Jane W Newburger
Journal:  J Pediatr       Date:  2010-12-18       Impact factor: 4.406

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

6.  Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression.

Authors:  Kyle Millar; Cedric Manlhiot; Rae S M Yeung; Zeeshanefatema Somji; Brian W McCrindle
Journal:  Int J Cardiol       Date:  2010-09-20       Impact factor: 4.164

7.  Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.

Authors:  Jane W Newburger; Lynn A Sleeper; Brian W McCrindle; L LuAnn Minich; Welton Gersony; Victoria L Vetter; Andrew M Atz; Jennifer S Li; Masato Takahashi; Annette L Baker; Steven D Colan; Paul D Mitchell; Gloria L Klein; Robert P Sundel
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

8.  External validation of a risk score to predict intravenous immunoglobulin resistance in patients with kawasaki disease.

Authors:  Mitsuru Seki; Tohru Kobayashi; Tomio Kobayashi; Akihiro Morikawa; Tetsuya Otani; Kazuo Takeuchi; Mamoru Ayusawa; Keiji Tsuchiya; Kenji Yasuda; Takahiro Suzuki; Shinya Shimoyama; Kentaro Ikeda; Yoichiro Ishii; Hirokazu Arakawa
Journal:  Pediatr Infect Dis J       Date:  2011-02       Impact factor: 2.129

9.  Resistance to intravenous immunoglobulin in children with Kawasaki disease.

Authors:  Adriana H Tremoulet; Brookie M Best; Sungchan Song; Susan Wang; Elena Corinaldesi; Julia R Eichenfield; Danielle D Martin; Jane W Newburger; Jane C Burns
Journal:  J Pediatr       Date:  2008-03-04       Impact factor: 4.406

10.  A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease.

Authors:  Bo-Hui Zhu; Hai-Tao Lv; Ling Sun; Jian-Min Zhang; Lei Cao; Hong-Liang Jia; Wen-Hua Yan; Yue-Ping Shen
Journal:  Eur J Pediatr       Date:  2011-11-05       Impact factor: 3.183
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.